Semaglutide 10mg Peptide

Semaglutide 10mg is a highly pure research peptide which comes in lyophilized form for research use only. As a GLP-1 receptor agonist, Semaglutide serves as an extensively characterized agent to help study the actions of glucagon-like peptide-1 receptor.
Each vial of Semaglutide 10mg contains 10mg of the substance in its pure form.

Semaglutide 10mg – GLP-1 Research Peptide

Semaglutide is a synthetic analogue of peptide hormone linked to the glucagon-like peptide-1 receptor pathway. The molecule of Semaglutide is altered from the naturally occurring GLP-1, resulting in a drug that has become highly researched in the metabolic, biochemical and receptor signalling sciences.
Contrary to the dual and triple agonist experimental compounds, Semaglutide acts on a single receptor, the GLP-1 receptor. This unique receptor action profile of Semaglutide can become useful in comparing the properties of single-receptor agonists with those of multi-receptor compounds.

Why Choose Semaglutide 10mg?

The 10mg presentation provides twice the total research material contained in a 5mg vial, making it a useful intermediate format for laboratory programmes requiring additional peptide from a single production batch.
A larger research quantity can be useful for comparative analytical procedures, repeated laboratory experiments or projects where consistency between samples is an important consideration.
Selecting the appropriate vial quantity can also help laboratories manage research materials more efficiently. Researchers should determine the required quantity according to their experimental design and established laboratory protocols.

Understanding GLP-1 Receptor Research

The glucagon-like peptide-1 receptor (GLP-1R) is a widely investigated receptor involved in biological and metabolic signalling.
Semaglutide functions as a GLP-1 receptor agonist, making it useful as a research compound for investigating receptor activation and downstream signalling under controlled laboratory conditions.
Its receptor selectivity also distinguishes it from Tirzepatide, which demonstrates activity at both GIP and GLP-1 receptors, and Retatrutide, which combines GIP, GLP-1 and glucagon receptor agonism.
These differences allow researchers to compare single-, dual- and triple-receptor mechanisms across experimental models.

99%+ Purity & Batch Documentation

Semaglutide 10mg is specified at 99%+ purity for laboratory research applications. Clearly defined purity and batch traceability are important considerations when researchers need to understand the characteristics of material incorporated into an experiment.
Where available, the relevant Certificate of Analysis (COA) should be reviewed for analytical information associated with the individual production batch.
Researchers should retain batch identifiers and supporting documentation with their laboratory records to help maintain traceability throughout a research programme.